MAPK3 and pulmonary fibrosis: Therefore, the present study aims to investigate the protective activity of vincamine against EMT in BLM-induced pulmonary fibrosis via assessing the apoptotic and TGF-β1/p38 MAPK/ERK1/2 signaling pathways.